Efficacy and tolerability of 16% subcutaneous immunoglobulin compared with 20% subcutaneous immunoglobulin in primary antibody deficiency. [electronic resource]
Producer: 20151117Description: 441-50 p. digitalISSN:- 1365-2249
- Adolescent
- Adult
- Aged
- Bacterial Infections -- immunology
- Child
- Child, Preschool
- Dose-Response Relationship, Drug
- Edema -- chemically induced
- Female
- Fever -- chemically induced
- Headache -- chemically induced
- Humans
- Immunoglobulin G -- administration & dosage
- Immunoglobulins -- administration & dosage
- Immunologic Deficiency Syndromes -- drug therapy
- Infusions, Subcutaneous
- Male
- Middle Aged
- Prospective Studies
- Quality of Life
- Surveys and Questionnaires
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.